INDYFINANCE
2026-10-08 UTC
 

News Archive

Every report the desk has filed, searchable by full text, topic, format, symbol and date range.

AstraZeneca Scraps Volrustomig Lung Trial as Enhertu Data Offsets Pipeline Setback

The FTSE-listed pharmaceutical group discontinued a late-stage lung cancer study of its bispecific candidate after a data setback, even as Enhertu delivered a progression-free survival benefit in a separate lung indication — leaving the stock higher on the day.

AstraZeneca discontinued a Phase 3 trial of volrustomig in lung cancer following disappointing data, a meaningful blow to its next-generation immuno-oncology ambitions. The negative headline was cushioned by positive progression-free survival results for Enhertu in a lung cancer setting, and shares traded higher as investors weighted the commercial-stage readout more heavily than the pipeline write-down.

BREAKING STORY
EnergyHealthcare & PharmaEquitiesAZN.LAZNFTSERead report →

Soft U.S. Retail Data Trims Fed Rate Bets, Lifting European Equities and Gold

Falling yields and repricing toward a Federal Reserve pause drove the FTSE 100 and continental benchmarks higher, with bullion catching a bid as the dollar's rate advantage narrowed.

European equity benchmarks ticked higher as weaker-than-expected U.S. retail sales prompted markets to trim expectations for further Federal Reserve tightening. Government bond yields eased across the curve, providing a valuation tailwind for long-duration equity sectors, while gold advanced as real-rate expectations softened.

MARKET REPORTBULLISH
Rates & BondsEquitiesCommoditiesFTSESTOXX50EN225XAUUSDARGX+1Read report →

China's July Data Miss Deepens Stimulus Debate as Industrial Output Slows to 4.5%

Industrial production undershoots consensus while retail sales grow just 0.6% year-on-year, reinforcing expectations of further policy support even as Chinese and Hong Kong equities rallied on a technology-led bid.

China's July activity data came in weaker than expected across both production and consumption, with industrial output up 4.5% y/y and retail sales advancing a bare 0.6%. The soft print sharpens the debate over the scale and timing of additional fiscal and monetary support, though equity markets in Shanghai and Hong Kong looked through the miss, led higher by technology names.

SPECIAL REPORTBEARISH
Consumer & RetailIndustrials & MaterialsAsiaHSI000001.SSFXIMCHIN225Read report →

KKR Rebuffed on First Gen as Philippine Central Bank Signals Gradual Disinflation

First Philippine Holdings rejects the US buyout group's offer for its power unit, while Bangko Sentral tempers easing expectations by flagging persistent upside inflation risks.

Two Philippine developments converged: First Philippine Holdings rejected KKR's approach for First Gen shares, and the central bank guided to only gradual inflation easing with risks skewed to the upside — a combination that constrains both M&A repricing and rate-cut positioning.

BREAKING STORY
Central BanksInflationBanking & FinanceFGEN.PSFPH.PSKKRRead report →

Alphabet Prepares Debut Kangaroo Bond as Big Tech Diversifies Funding Away from Dollar Markets

Bookrunner messaging points to an inaugural Australian dollar issue from the search giant, extending the megacap capital-raising cycle into secondary currency markets to fund AI infrastructure build-out.

Alphabet is sounding out an inaugural Australian dollar bond, according to a bookrunner message, marking the latest step in hyperscaler funding diversification as AI capital expenditure outstrips operating cash generation.

BREAKING STORY
Rates & BondsAI & SemiconductorsGOOGLGOOGNVDARead report →

Australian Earnings Season Turns Defensive as JB Hi-Fi Guidance Miss Overshadows Aurizon Profit Surge

Retailer's warning on a weak start to FY27 sends shares sliding, while Aurizon's 24% earnings jump fails to prevent a 10% drawdown — a market punishing forward guidance over trailing performance.

The ASX reporting season delivered a stark divergence between reported results and share price reactions. JB Hi-Fi tumbled on soft FY27 commentary, Aurizon fell 10% despite a 24% profit surge, and a2 Milk, Iress, New Hope and Australian Clinical Labs added to a crowded, guidance-sensitive tape.

SPECIAL REPORTBEARISH
EarningsConsumer & RetailJBH.AXAZJ.AXA2M.AXIRE.AXNHC.AX+3Read report →

Insider Selling Wave Sweeps US Corporates as Executives Cash Out Across Tech, Healthcare and Media

More than a dozen Form 4 disclosures in 24 hours — led by Thermo Fisher CEO Marc Casper's $8.6m disposal and Magnite's $660k of combined executive sales — point to a broad monetisation impulse at elevated equity valuations.

A dense cluster of insider disposals spanning Thermo Fisher, Block, Magnite, Colgate-Palmolive, IFF, Aurora Innovation, Tenet Healthcare, Accel Entertainment, Cohen & Co, Gevo and Warner Bros. Discovery signals executives are trimming exposure after a powerful equity run. While individually routine, the aggregate pattern is a classic late-cycle tell.

SPECIAL REPORTBEARISH
TMOXYZMGNICLIFF+6Read report →

Trump Orders Pentagon to Curtail South Korea Military Drills, Reshaping Asian Geopolitical Risk

President frames joint exercises as sending a 'hostile' signal to Pyongyang, a policy pivot with implications for defence spending assumptions and regional risk premia.

President Trump has asked the Pentagon to scale back joint military exercises with South Korea, characterising them as provocative toward North Korea. The move injects fresh uncertainty into North Asian security arrangements and the alliance-linked defence procurement outlook.

SPECIAL REPORT
GeopoliticsAsiaKEPEWYKS11CL=FRead report →

Futures Idle as Wall Street Waits for the Fed — and Watches the Warsh Succession Trade

Stock-index futures were little changed into the new week as investors weigh the policy path, with strategists now openly pricing leadership risk at the Federal Reserve.

U.S. equity futures were broadly flat following a quiet week, with positioning frozen ahead of clearer signals on the Fed's rate trajectory. Commentary around a potential Warsh-led Fed is injecting an institutional-credibility variable into rates markets alongside conventional data dependency.

SPECIAL REPORT
Central BanksUnited StatesGSPCIXICTNXVIXRead report →

Smart Money Splinters on Nvidia as AI Capex Cycle Approaches $600 Billion

Tepper adds, Loeb exits entirely and Soros buys puts, exposing a widening institutional divide over whether hyperscaler capital spending is a durable earnings engine or a late-cycle peak.

Divergent positioning among high-profile investors in Nvidia — accumulation, full liquidation and outright put buying — highlights unresolved disagreement over the sustainability of AI infrastructure spending, even as Amazon, Alphabet and Microsoft commit close to $600 billion in capital expenditure.

SPECIAL REPORT
EarningsAI & SemiconductorsNVDAAMZNGOOGLMSFTTSLA+1Read report →

a2 Milk Profit Collapses 44% as China Supply Chain Rupture Overwhelms Topline Growth

New Zealand infant formula group's FY earnings slump on China distribution disruptions, sending shares sharply lower and reframing the ANZ consumer-staples China exposure debate.

a2 Milk reported a 44% slide in full-year profit as supply disruptions in its critical China channel undercut margins, triggering a steep single-day selloff. The result reasserts China execution risk as the dominant variable for Australasian branded consumer exporters.

BREAKING STORYBEARISH
EarningsShipping & LogisticsAsiaA2M.AXATM.NZFRE.NZAGL.AXRead report →

Dimon Lobbies Whitehall Against Bank Tax Rise Ahead of October Budget

The JPMorgan chief executive personally called UK ministers to warn that higher levies on financial services would undermine London's competitiveness, in the most senior intervention yet in an escalating industry campaign.

Jamie Dimon has directly warned the UK government against raising bank taxes in the October Budget, part of a coordinated financial services lobbying effort. The intervention crystallises a policy risk hanging over UK-listed lenders and the broader City investment case.

BREAKING STORYBEARISH
Banking & FinanceJPMBARC.LLLOY.LNWG.LHSBA.L+1Read report →

Oil Majors Book $93bn Windfall From Iran Conflict as Geopolitical Risk Premium Persists

Integrated energy producers captured an extraordinary earnings uplift from war-driven crude pricing, even as escalatory rhetoric from Israeli minister Itamar Ben-Gvir signals the Middle East risk premium is unlikely to decay quickly.

The world's largest oil companies reaped a $93 billion windfall from the Iran war, a transfer of value from consumers to producers that has materially reset energy sector free cash flow expectations. Continued hardline political signalling in Israel suggests the underlying geopolitical premium remains structurally embedded in crude.

SPECIAL REPORTBULLISH
GeopoliticsEarningsEnergyXOMCVXSHEL.LBP.LTTE.PA+2Read report →

Steepening Curve Puts 20-Year Auction on Trial as Global Yields Hit Bitcoin-Era Highs

A US 20-year bond sale arrives into the steepest curve of the cycle, while global long-end yields reach levels never before experienced during Bitcoin's entire existence — a structural stress test for duration-sensitive and speculative assets alike.

The Treasury's 20-year auction becomes the session's marquee risk event as term premium rebuilds and the curve steepens. Simultaneously, global bond yields have reached levels unseen since Bitcoin's 2009 inception, removing the zero-cost-of-capital backdrop that underpinned the entire digital asset era.

BREAKING STORYBEARISH
Rates & BondsCrypto & Digital AssetsTNXTYXBTC-USDTLTIBITRead report →

Insider Selling Wave Broadens Across Mid-Cap America as Executives Cash Into Strength

Encompass Health's CEO and CFO, Savers Value Village's entire senior bench, SharkNinja, Scholastic, Natera and AppFolio insiders all disclosed disposals within a single wire cycle — a breadth of distribution that historically accompanies late-cycle valuation stress.

A dense cluster of Form 4 disclosures spanning healthcare services, consumer retail, diagnostics, consumer durables and software points to coordinated executive de-risking into post-earnings rallies. Encompass Health saw three separate insiders sell after a rate increase, with the CFO cutting his direct common position 27% and CEO Mark Tarr trimming while retaining roughly 268,000 shares worth $33.7 million.

SPECIAL REPORTBEARISH
EarningsEHCSVVSNSCHLNTRA+1Read report →

Q2 Earnings Season Breaks Its Own Rules as Share-Price Reactions Decouple From Results

Historic reporting volume is producing increasingly random post-print moves, while AbbVie's neuroscience franchise emerges as a $12.7 billion sleeper business

Analysts flag a widening disconnect between reported fundamentals and share-price reactions during a historic Q2 earnings season, complicating event-driven positioning. AbbVie's guidance for $12.7 billion in neuroscience sales this year is a case study in fundamentals the market has been slow to price.

BREAKING STORY
EarningsABBVAMATPUBMSCHLRead report →

Income Rotation: High-Dividend Strategies Outrun the S&P 500 by Nine Points in 2026

Yield-oriented ETFs, midstream energy distribution hikes and reinsurance payouts are drawing capital as investors interrogate the composition of dividend benchmarks

High-dividend ETF strategies are outperforming the S&P 500 by roughly nine percentage points in 2026, prompting closer scrutiny of index construction. Meanwhile Energy Transfer raised 2026 guidance, Delek Logistics lifted its distribution, and Swiss Re is being underwritten for a 5.1% forward yield.

SPECIAL REPORTBULLISH
Rates & BondsEarningsEquitiesVIGIYKETDKLSREN.SW+1Read report →

September Fed Hike Odds Collapse to 25% as Betting Markets Diverge From Rate Strategists

Prediction-market pricing for a September tightening has plunged, but analysts warn positioning is vulnerable to a hawkish repricing if broadening earnings strength pressures the inflation path

Implied odds of a September Federal Reserve rate hike have fallen to roughly 25%, a sharp dovish repricing that some strategists argue is complacent. With corporate earnings growth broadening beyond technology and financials positioned as beneficiaries, the risk of a hawkish surprise is being underpriced.

BREAKING STORY
Central BanksInflationEarningsGSPCTNXXLFMSRead report →

AI Capex Cycle Enters Payoff Phase as Alphabet Lifts Spend to $205 Billion, Cloud Backlog Swells to $514 Billion

Wall Street strategists shift narrative from 'spending risk' to 'spending-to-earnings conversion' as hyperscaler backlogs, memory pricing and semicap records validate the infrastructure buildout

Alphabet's raised 2026 capital expenditure guidance to $205 billion arrived alongside a $514 billion Google Cloud backlog, reframing the AI investment debate around revenue conversion rather than balance-sheet strain. Strategists now argue spending is directly feeding earnings, a thesis reinforced by SK Hynix's blowout week, record Applied Materials revenue and Nvidia's growing role as system-wide financier of the AI supply chain.

SPECIAL REPORTBULLISH
EarningsAI & SemiconductorsUnited StatesGOOGLNVDAAMAT000660.KSTTMI+2Read report →

Defensive Compounders Reassert Leadership as Growth Names Fracture

Coca-Cola's 64th consecutive dividend increase is outpacing the Magnificent Seven year-to-date while Netflix trades nearly 40% off highs and The Trade Desk suffers a violent de-rating, exposing a widening dispersion regime.

Dividend aristocrats are outperforming mega-cap growth in a year defined by sharp single-name drawdowns. Netflix is down almost 40%, The Trade Desk has crashed, and value-oriented names across consumer, chemicals and energy infrastructure are drawing renewed institutional attention.

MARKET REPORT
KONFLXTTDALBLB+4Read report →
Most covered symbols
NVDAGSPCMUTNXAMDGOOGLBTCBTC-USDAVGOMETATLTMSFTIXICAAPLAMZNGLDTSLABABACL=FCRWVBACLCOINDXYINTC000660.KSMSTRUSDJPYUSODELLNBISPLTRSNDKTSMWBDNDXBRK.BETHHOODORCL

Each chip opens the Research terminal for that symbol, where its archive coverage is listed alongside the fundamentals.